October 28th- Beyond the Webinar: Anti-CD38 mAb-based strategies across the myeloma continuum CME Congresses . October 28th- Beyond the Webinar: Anti-CD38 mAb-based strategies across the myeloma continuum October 26th- From IMiDs to CELMoDs: 30 Years of Cereblon Biology in Multiple Myeloma CME Congresses . October 26th- From IMiDs to CELMoDs: 30 Years of Cereblon Biology in Multiple Myeloma October 22nd- Beyond the Webinar: CELMoDs in Multiple Myeloma: A New Era of Cereblon Modulation CME Congresses . October 22nd- Beyond the Webinar: CELMoDs in Multiple Myeloma: A New Era of Cereblon Modulation October 19th- Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma CME Congresses . October 19th- Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma October 13th- Beyond the Webinar: The 23rd International Myeloma Society Congress in Glasgow CME Congresses . October 13th- Beyond the Webinar: The 23rd International Myeloma Society Congress in Glasgow October 19th- Teclistamab in high-risk smoldering multiple myeloma CME Congresses . October 19th- Teclistamab in high-risk smoldering multiple myeloma October 12th- Beyond the Webinar: MRD in Multiple Myeloma: From Measuring Response to Guiding Treatment CME Congresses . October 12th- Beyond the Webinar: MRD in Multiple Myeloma: From Measuring Response to Guiding Treatment October 19th- Myélome et MRD : de la prédiction à la décision! CME Congresses . October 19th- Myélome et MRD : de la prédiction à la décision! October 12th- Actualités du Congrès IMS 2026 CME Congresses . October 12th- Actualités du Congrès IMS 2026 October 9th- Beyond Baseline Risk: Dynamic MRD-Driven Prognostication in CLL CME Congresses . October 9th- Beyond Baseline Risk: Dynamic MRD-Driven Prognostication in CLL Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Page21 Page22 Page23 Page24 Page25 Page26 Page27
